2m 2m 2m 2m 2m 2m 2m
Macrogenics (MGNX)
NASDAQ
$3.58-$0.02 (-0.69%)
Price as of Oct 02, 2026 4:10 PM EDT- $229.3MMarket Cap
- 110.53%1-Year Change
- BiotechnologyIndustry
Macrogenics (MGNX)
$3.58-$0.02 (-0.69%)
MGNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.60 | ||
Change | -$0.26 (-6.74%) | ||
Open | $3.85 | ||
High | $3.88 | ||
Low | $3.58 | ||
Previous Close | $3.86 | ||
Volume | 656,628 | ||
30-Day Average Volume | 562,284 | ||
1-Week Change | -5.26% | ||
1-Month Change | -10.89% | ||
1-Year Change | 110.53% | ||
3-Year Change | -22.75% | ||
5-Year Change | -83.21% | ||
Fundamentals | |||
Shares Outstanding | 63.7M | ||
Total Assets | $345.4M | ||
Market Cap | $229.3M | ||
Enterprise Value | $115.4M | ||
Period: QTR TTM FY | |||
Revenue | $25.5M | ||
Net Income | $19.5M | ||
Free Cash Flow | -$41.6M | ||
EBIT | $23.9M | ||
EBITDA | $24.6M | ||
Net Working Capital | $212.9M | ||
EPS | $0.31 | ||
Enterprise Value/EBITDA | 5 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 5 | ||
P/E | 12 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue